Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Inactivation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kits and Reagents
1.2.3 Services
1.2.4 Viral Inactivation Systems and Accessories
1.3 Market by Application
1.3.1 Global Viral Inactivation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood and Blood Products
1.3.3 Cellular and Gene Therapy Products
1.3.4 Stem Cell Products
1.3.5 Tissue and Tissue Products
1.3.6 Vaccines and Therapeutics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Inactivation Market Perspective (2019-2030)
2.2 Viral Inactivation Growth Trends by Region
2.2.1 Global Viral Inactivation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Inactivation Historic Market Size by Region (2019-2024)
2.2.3 Viral Inactivation Forecasted Market Size by Region (2025-2030)
2.3 Viral Inactivation Market Dynamics
2.3.1 Viral Inactivation Industry Trends
2.3.2 Viral Inactivation Market Drivers
2.3.3 Viral Inactivation Market Challenges
2.3.4 Viral Inactivation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Inactivation Players by Revenue
3.1.1 Global Top Viral Inactivation Players by Revenue (2019-2024)
3.1.2 Global Viral Inactivation Revenue Market Share by Players (2019-2024)
3.2 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Inactivation Revenue
3.4 Global Viral Inactivation Market Concentration Ratio
3.4.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2023
3.5 Viral Inactivation Key Players Head office and Area Served
3.6 Key Players Viral Inactivation Product Solution and Service
3.7 Date of Enter into Viral Inactivation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Inactivation Breakdown Data by Type
4.1 Global Viral Inactivation Historic Market Size by Type (2019-2024)
4.2 Global Viral Inactivation Forecasted Market Size by Type (2025-2030)
5 Viral Inactivation Breakdown Data by Application
5.1 Global Viral Inactivation Historic Market Size by Application (2019-2024)
5.2 Global Viral Inactivation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Inactivation Market Size (2019-2030)
6.2 North America Viral Inactivation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Inactivation Market Size by Country (2019-2024)
6.4 North America Viral Inactivation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Inactivation Market Size (2019-2030)
7.2 Europe Viral Inactivation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Inactivation Market Size by Country (2019-2024)
7.4 Europe Viral Inactivation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Inactivation Market Size (2019-2030)
8.2 Asia-Pacific Viral Inactivation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Inactivation Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Inactivation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Inactivation Market Size (2019-2030)
9.2 Latin America Viral Inactivation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Inactivation Market Size by Country (2019-2024)
9.4 Latin America Viral Inactivation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Inactivation Market Size (2019-2030)
10.2 Middle East & Africa Viral Inactivation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Inactivation Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Inactivation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Detail
11.1.2 Danaher Business Overview
11.1.3 Danaher Viral Inactivation Introduction
11.1.4 Danaher Revenue in Viral Inactivation Business (2019-2024)
11.1.5 Danaher Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Viral Inactivation Introduction
11.2.4 Merck Revenue in Viral Inactivation Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Parker Hannifin
11.3.1 Parker Hannifin Company Detail
11.3.2 Parker Hannifin Business Overview
11.3.3 Parker Hannifin Viral Inactivation Introduction
11.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2019-2024)
11.3.5 Parker Hannifin Recent Development
11.4 Sartorius
11.4.1 Sartorius Company Detail
11.4.2 Sartorius Business Overview
11.4.3 Sartorius Viral Inactivation Introduction
11.4.4 Sartorius Revenue in Viral Inactivation Business (2019-2024)
11.4.5 Sartorius Recent Development
11.5 SGS
11.5.1 SGS Company Detail
11.5.2 SGS Business Overview
11.5.3 SGS Viral Inactivation Introduction
11.5.4 SGS Revenue in Viral Inactivation Business (2019-2024)
11.5.5 SGS Recent Development
11.6 Charles River Laboratories International
11.6.1 Charles River Laboratories International Company Detail
11.6.2 Charles River Laboratories International Business Overview
11.6.3 Charles River Laboratories International Viral Inactivation Introduction
11.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2019-2024)
11.6.5 Charles River Laboratories International Recent Development
11.7 Clean Cells
11.7.1 Clean Cells Company Detail
11.7.2 Clean Cells Business Overview
11.7.3 Clean Cells Viral Inactivation Introduction
11.7.4 Clean Cells Revenue in Viral Inactivation Business (2019-2024)
11.7.5 Clean Cells Recent Development
11.8 Rad Source Technologies
11.8.1 Rad Source Technologies Company Detail
11.8.2 Rad Source Technologies Business Overview
11.8.3 Rad Source Technologies Viral Inactivation Introduction
11.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2019-2024)
11.8.5 Rad Source Technologies Recent Development
11.9 Texcell
11.9.1 Texcell Company Detail
11.9.2 Texcell Business Overview
11.9.3 Texcell Viral Inactivation Introduction
11.9.4 Texcell Revenue in Viral Inactivation Business (2019-2024)
11.9.5 Texcell Recent Development
11.10 Viral Inactivated Plasma Systems
11.10.1 Viral Inactivated Plasma Systems Company Detail
11.10.2 Viral Inactivated Plasma Systems Business Overview
11.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
11.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2019-2024)
11.10.5 Viral Inactivated Plasma Systems Recent Development
11.11 Wuxi Pharmatech (Cayman)
11.11.1 Wuxi Pharmatech (Cayman) Company Detail
11.11.2 Wuxi Pharmatech (Cayman) Business Overview
11.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
11.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2019-2024)
11.11.5 Wuxi Pharmatech (Cayman) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details